Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTSH
2476
DELISTED
Tile Shop Holdings
TTSH
| $762K | ﹤0.01% |
110,000
+27,200
| +33% | +$182K |
|
2477
Lifestance Health
LFST
$4.86B
| $761K | ﹤0.01% |
155,000
-105,700
| -41% | -$637K |
|
2478
Coffee Holding Co
JVA
$20.1M
| $759K | ﹤0.01% |
324,564
+8,900
| +3% | +$13.6K |
|
2479
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.46B
| $758K | ﹤0.01% |
5,900
+3,900
| +195% | +$499K |
|
|
CLSD
2480
DELISTED
Clearside Biomedical
CLSD
| $757K | ﹤0.01% |
38,846
+2,393
| +7% | +$46.2K |
|
2481
ThredUp
TDUP
$406M
| $756K | ﹤0.01% |
444,412
+91,708
| +26% | +$167K |
|
2482
Assembly Biosciences
ASMB
$626M
| $753K | ﹤0.01% |
54,911
+15,451
| +39% | +$220K |
|
2483
Ponce Financial Group
PDLB
$505M
| $753K | ﹤0.01% |
82,394
-1,500
| -2% | -$13K |
|
|
TAIT
2484
DELISTED
Taitron Components
TAIT
| $751K | ﹤0.01% |
283,546
-17,227
| -6% | -$51.6K |
|
2485
V2X
VVX
$2.61B
| $748K | ﹤0.01% |
15,600
-4,600
| -23% | -$218K |
|
|
IGMS
2486
DELISTED
IGM Biosciences
IGMS
| $747K | ﹤0.01% |
108,693
+60,593
| +126% | +$518K |
|
2487
PLAYSTUDIOS Inc
MYPS
$64.6M
| $745K | ﹤0.01% |
360,000
+63,800
| +22% | +$150K |
|
2488
Orthofix Medical
OFIX
$419M
| $744K | ﹤0.01% |
56,071
-61,465
| -52% | -$842K |
|
|
SLN
2489
Silence Therapeutics
SLN
$642M
| $743K | ﹤0.01% |
39,100
-64,800
| -62% | -$1.38M |
|
2490
Wipro
WIT
$19.4B
| $737K | ﹤0.01% |
+241,800
| New | +$666K |
|
2491
NextCure
NXTC
$35.5M
| $735K | ﹤0.01% |
38,512
+5,145
| +15% | +$100K |
|
|
SNCR
2492
DELISTED
Synchronoss Technologies
SNCR
| $734K | ﹤0.01% |
78,974
+6,700
| +9% | +$54.5K |
|
2493
Nortech Systems
NSYS
$34.6M
| $734K | ﹤0.01% |
53,799
+3,540
| +7% | +$49.8K |
|
|
CODX
2494
Co-Diagnostics
CODX
$5.16M
| $734K | ﹤0.01% |
19,567
-446
| -2% | -$16.2K |
|
2495
iShares MSCI Taiwan ETF
EWT
$11.5B
| $732K | ﹤0.01% |
13,500
-13,200
| -49% | -$661K |
|
|
NXDT
2496
NexPoint Diversified Real Estate Trust
NXDT
$267M
| $730K | ﹤0.01% |
+132,063
| New | +$753K |
|
|
VBTX
2497
DELISTED
Veritex Holdings
VBTX
| $730K | ﹤0.01% |
+34,623
| New | +$700K |
|
|
MURA
2498
DELISTED
Mural Oncology
MURA
| $729K | ﹤0.01% |
232,100
+15,100
| +7% | +$55.7K |
|
2499
Simplify Interest Rate Hedge ETF
PFIX
$180M
| $727K | ﹤0.01% |
15,200
-2,200
| -13% | -$108K |
|
|
MRNS
2500
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $727K | ﹤0.01% |
+621,625
| New | +$1.56M |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.